Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Forte Biosciences
FBRX
$153M
| $620K | ﹤0.01% |
681
+188
| +38% | +$171K |
|
2727
Scansource
SCSC
$962M
| $620K | ﹤0.01% |
23,510
-35,700
| -60% | -$941K |
|
|
ZEAL
2728
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $618K | ﹤0.01% |
17,205
-5,995
| -26% | -$215K |
|
2729
iShares Core 80/20 Aggressive Allocation ETF
AOA
$2.59B
| $616K | ﹤0.01% |
9,600
+5,809
| +153% | +$373K |
|
2730
Bank of Montreal
BMO
$93B
| $615K | ﹤0.01% |
8,095
-218,700
| -96% | -$16.6M |
|
|
FFG
2731
DELISTED
FBL Financial Group
FFG
| $615K | ﹤0.01% |
11,710
-29,490
| -72% | -$1.55M |
|
2732
Kopin
KOPN
$394M
| $611K | ﹤0.01% |
+251,391
| New | +$611K |
|
|
MYND
2733
Mynd.ai
MYND
$37.2M
| $610K | ﹤0.01% |
25,721
-421
| -2% | -$9.98K |
|
2734
ASGN Inc
ASGN
$2.17B
| $609K | ﹤0.01% |
+7,294
| New | +$609K |
|
|
MDNA
2735
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $608K | ﹤0.01% |
130,500
-99,400
| -43% | -$463K |
|
2736
Perspective Therapeutics
CATX
$226M
| $607K | ﹤0.01% |
134,853
+83,783
| +164% | +$377K |
|
|
TSRI
2737
DELISTED
TSR Inc. New
TSRI
| $607K | ﹤0.01% |
86,750
-323
| -0.4% | -$2.26K |
|
2738
Inspired Entertainment
INSE
$248M
| $606K | ﹤0.01% |
92,057
+19,287
| +27% | +$127K |
|
|
RGLS
2739
DELISTED
Regulus Therapeutics
RGLS
| $606K | ﹤0.01% |
+44,920
| New | +$606K |
|
2740
FibroGen
FGEN
$46.5M
| $605K | ﹤0.01% |
+652
| New | +$605K |
|
|
CCM
2741
Concord Medical Services
CCM
$25M
| $604K | ﹤0.01% |
22,040
-1,790
| -8% | -$49.1K |
|
2742
Dayforce
DAY
$10.9B
| $596K | ﹤0.01% |
5,600
+200
| +4% | +$21.3K |
|
|
ASLN
2743
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $595K | ﹤0.01% |
8,123
+6,175
| +317% | +$452K |
|
2744
Jerash Holdings
JRSH
$43.6M
| $592K | ﹤0.01% |
101,246
+45,000
| +80% | +$263K |
|
2745
UroGen Pharma
URGN
$837M
| $591K | ﹤0.01% |
+32,800
| New | +$591K |
|
|
SUNW
2746
DELISTED
Sunworks, Inc.
SUNW
| $591K | ﹤0.01% |
+115,398
| New | +$591K |
|
2747
Urban One Class D
UONEK
$35.6M
| $590K | ﹤0.01% |
504,000
-386,809
| -43% | -$453K |
|
2748
Penske Automotive Group
PAG
$11.8B
| $588K | ﹤0.01% |
+9,900
| New | +$588K |
|
2749
PENN Entertainment
PENN
$2.76B
| $587K | ﹤0.01% |
6,800
-237,502
| -97% | -$20.5M |
|
|
SUPV
2750
Grupo Supervielle
SUPV
$490M
| $587K | ﹤0.01% |
+276,956
| New | +$587K |
|